167 related articles for article (PubMed ID: 9169727)
1. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
2. Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.
Bielaszewska M; Clarke I; Karmali MA; Petric M
Infect Immun; 1997 Jul; 65(7):2509-16. PubMed ID: 9199412
[TBL] [Abstract][Full Text] [Related]
3. Murine antibody responses to the verotoxin 1 B subunit: demonstration of major histocompatibility complex dependence and an immunodominant epitope involving phenylalanine 30.
Bast DJ; Sandhu J; Hozumi N; Barber B; Brunton J
Infect Immun; 1997 Jul; 65(7):2978-82. PubMed ID: 9199476
[TBL] [Abstract][Full Text] [Related]
4. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
Kiarash A; Boyd B; Lingwood CA
J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
[TBL] [Abstract][Full Text] [Related]
5. Experimental verocytotoxemia in rabbits.
Richardson SE; Rotman TA; Jay V; Smith CR; Becker LE; Petric M; Olivieri NF; Karmali MA
Infect Immun; 1992 Oct; 60(10):4154-67. PubMed ID: 1398926
[TBL] [Abstract][Full Text] [Related]
6. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
Devenish J; Gyles C; LaMarre J
Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
[TBL] [Abstract][Full Text] [Related]
7. Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid.
Ludwig K; Karmali MA; Smith CR; Petric M
Can J Microbiol; 2002 Jan; 48(1):99-103. PubMed ID: 11888169
[TBL] [Abstract][Full Text] [Related]
8. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.
Itoh K; Tezuka T; Inoue K; Tada H; Suzuki T
Tohoku J Exp Med; 2001 Dec; 195(4):237-43. PubMed ID: 11908825
[TBL] [Abstract][Full Text] [Related]
9. Phenylalanine 30 plays an important role in receptor binding of verotoxin-1.
Clark C; Bast D; Sharp AM; St Hilaire PM; Agha R; Stein PE; Toone EJ; Read RJ; Brunton JL
Mol Microbiol; 1996 Feb; 19(4):891-9. PubMed ID: 8820657
[TBL] [Abstract][Full Text] [Related]
10. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
Boyd B; Tyrrell G; Maloney M; Gyles C; Brunton J; Lingwood C
J Exp Med; 1993 Jun; 177(6):1745-53. PubMed ID: 8496689
[TBL] [Abstract][Full Text] [Related]
11. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.
Rutjes NW; Binnington BA; Smith CR; Maloney MD; Lingwood CA
Kidney Int; 2002 Sep; 62(3):832-45. PubMed ID: 12164865
[TBL] [Abstract][Full Text] [Related]
12. Localization of the binding site for modified Gb3 on verotoxin 1 using fluorescence analysis.
Picking WD; McCann JA; Nutikka A; Lingwood CA
Biochemistry; 1999 Jun; 38(22):7177-84. PubMed ID: 10353828
[TBL] [Abstract][Full Text] [Related]
13. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit.
Bast DJ; Banerjee L; Clark C; Read RJ; Brunton JL
Mol Microbiol; 1999 Jun; 32(5):953-60. PubMed ID: 10361298
[TBL] [Abstract][Full Text] [Related]
14. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function.
Head SC; Karmali MA; Lingwood CA
J Biol Chem; 1991 Feb; 266(6):3617-21. PubMed ID: 1847382
[TBL] [Abstract][Full Text] [Related]
15. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies.
Tam P; Mahfoud R; Nutikka A; Khine AA; Binnington B; Paroutis P; Lingwood C
J Cell Physiol; 2008 Sep; 216(3):750-63. PubMed ID: 18446787
[TBL] [Abstract][Full Text] [Related]
16. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
Padhye VV; Zhao T; Doyle MP
J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
[TBL] [Abstract][Full Text] [Related]
17. Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls.
Bitzan M; Klemt M; Steffens R; Müller-Wiefel DE
Infection; 1993; 21(3):140-5. PubMed ID: 8365810
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157:H7 in mice.
Kuribayashi T; Seita T; Fukuyama M; Furuhata K; Honda M; Matsumoto M; Seguchi H; Yamamoto S
J Infect Chemother; 2006 Oct; 12(5):251-6. PubMed ID: 17109087
[TBL] [Abstract][Full Text] [Related]
19. Verotoxin 1 from Escherichia coli affects Gb3/CD77+ bovine lymphocytes independent of interleukin-2, tumor necrosis factor-alpha, and interferon-alpha.
Menge C; Stamm I; Blessenohl M; Wieler LH; Baljer G
Exp Biol Med (Maywood); 2003 Apr; 228(4):377-86. PubMed ID: 12671182
[TBL] [Abstract][Full Text] [Related]
20. Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology.
Lingwood CA
Biochim Biophys Acta; 1999 Oct; 1455(2-3):375-86. PubMed ID: 10571026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]